ScholarIQanswers from OpenAlex & ORCID
Marvin S. Swartz
ResearcherPublications, citations & collaboration network
Marvin S. Swartz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marvin S. Swartz have?
ScholarIQindexed works
Marvin S. Swartz has 376 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marvin S. Swartz have?
ScholarIQcitation count
Marvin S. Swartz has 29,184 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marvin S. Swartz?
ScholarIQh-index
Marvin S. Swartz has an h-index of 82 in OpenAlex.
What is the i10-index of Marvin S. Swartz?
ScholarIQi10-index
Marvin S. Swartz has an i10-index of 228 in OpenAlex.
What is the ORCID of Marvin S. Swartz?
ScholarIQorcid
The ORCID for Marvin S. Swartz is on the source record.
What is the OpenAlex record for Marvin S. Swartz?
ScholarIQopenalex
The OpenAlex for Marvin S. Swartz is on the source record.
What are the most-cited papers on Marvin S. Swartz?
ScholarIQmost cited works
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Sonia M. Davis, C.E. Davis, Barry D. Lebowitz, Joanne B. Severe, John Hsiao
A National Study of Violent Behavior in Persons With Schizophrenia
Jeffrey W. Swanson, Marvin S. Swartz, Richard A. Van Dorn, Eric B. Elbogen, Henry R. Wagner, Robert A. Rosenheck, T. Scott Stroup, Joseph P. McEvoy, Jeffrey A. Lieberman
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup, Sonia M. Davis, Herbert Y. Meltzer, Robert A. Rosenheck, Marvin S. Swartz, Diana O. Perkins, Richard S.E. Keefe, C.E. Davis, Joanne B. Severe, John Hsiao, for the CATIE Investigators
Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care
Haya Ascher‐Svanum, Douglas E. Faries, Baojin Zhu, Frank R. Ernst, Marvin S. Swartz, Jeff W. Swanson
Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
Robert A. Rosenheck, Douglas Leslie, Jody L. Sindelar, Edward Alan Miller, Haiqun Lin, T. Scott Stroup, Joseph McEvoy, Sonia M. Davis, Richard S.E. Keefe, Marvin S. Swartz, Diana O. Perkins, John Hsiao, Jeffrey A. Lieberman